Navigation Links
Shire plc: IFRS Results for the Year Ending December 31, 2007
Date:3/25/2008

8.2 11.8

Cash and cash equivalents 762.5 1,126.9

Restricted cash 39.5 29.8

Assets held for sale 14.7 -

__________ __________

1,542.3 1,695.7

__________ __________

Total assets 8,894.9 5,696.6

__________ __________

LIABILITIES AND SHAREHOLDERS' EQUITY

Non-current liabilities

Convertible bonds 8 910.2 -

Other borrowings 7.9 6.9

Trade and other payables 34.3 24.6

Deferred tax liabilities 1,093.9 147.2

Long-term provisions 20.5 27.6

__________ __________

2,066.8 206.3

__________ __________

Current liabilities

Other borrowings 4.7 3.5

Trade and other payables 678.2 585.5

Liability to dissenting shareholders 480.2 452.3

Current tax liabilities 390.2 295.3

Provisions 56.2 8.3

__________ __________

1,609.5 1,344.9

__________ __________

Total liabilities
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
2. Shire plc: Correction Re Website
3. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
4. Shire Engages Palio
5. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
6. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
7. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
8. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
9. Shire plc: Board Changes
10. David Mott Appointed Non Executive Director at Shire
11. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... June 29, 2015 ... the addition of the "Biotechnology for the ... Biotechnology for the Non-Biotechnologist, ideal for non-Scientists and ... techniques and potential of biotechnology. Ideal ... basic theory, principles, techniques, and potential of biotechnology ...
(Date:7/6/2015)... , July 6, 2015 ImmunoCellular Therapeutics, Ltd. ... an agreement with Novella Clinical (Novella), to ... patients with newly diagnosed glioblastoma. Novella is a full-service, ... to small to mid-sized oncology companies. The ICT-107 phase ... the US, Europe and ...
(Date:7/3/2015)... WIEN , July 3, ... Tiedemiehet voivat hakea verkossa osoitteessa  ... for Open Innovation in Science" ... Ludwig Boltzmann Gesellschaftin (LBG) tekemän, ... tutkimuksen mukaan terveystieteiden kaksi suurinta ...
(Date:7/3/2015)... , July 3, 2015 ... 22 september 2015 på  http://www.openinnovationinscience.at till ... in Science" som hålls i ... färsk undersökning med internationella forskare och vetenskapsmän ... är hälsovetenskapens två största utmaningar bristen på ...
Breaking Biology Technology:ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3
... , , , , ... /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical Co., Inc., (NYSE Amex: TPI ), ... Western Pharmaceuticals,based in Chengdu, China , today announced that ... of Pricing Mechanism of Medicine,and Medical Services by the Chinese ...
... , , SILVER SPRING, Md. ... UTHR ) announced today that it will release its ... on Tuesday, February 16, 2010 . , United Therapeutics ... 2010 , at 9:00 a.m. Eastern Time .  The ...
... , , , , , , ... Feb. 9 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc.,(NYSE Amex: NBS ) ... U.S. and China , announced,today that its stem cell collection ... addition of the physician group at Westlake,Orthopaedics Spine & Sports ("Westlake") ...
Cached Biology Technology:Tianyin Pharmaceutical Co., Inc. Expects to Benefit from the Recently Published Guide to Pricing Reform for Medicine and Medical Services 2Tianyin Pharmaceutical Co., Inc. Expects to Benefit from the Recently Published Guide to Pricing Reform for Medicine and Medical Services 3Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network 2Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network 3Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network 4
(Date:6/24/2015)... June 22, 2015 ... addition of the "Huawei Ascend Mate 7 ... to their offering. Huawei,s technological choice ... opposite direction than Apple,s and Samsung,s one. The ... developed by Fingerprint Cards, a main actor in ...
(Date:6/23/2015)... June 23, 2015  Crossmatch™, a leading ... today announced enhanced functionality of its DigitalPersona ... The enhancements build on the native flexibility ... Altus platform and provide expanded mobile credential ... In today,s environment of increasing cyber-attacks and ...
(Date:6/17/2015)... June 17, 2015  Synaptics Inc. (NASDAQ: ... today announced that Xiaomi, one of the world,s ... ClearPad ® family of capacitive touchscreen ... circuits (DDICs) for its latest smartphones, the Xiaomi ... for full in-cell display solutions and DDICs in ...
Breaking Biology News(10 mins):Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
... was to test a computer algorithms ability to identify ... classify them according to different contexts and individual dogs. ... Hungarian sheepdogs (Mudi breed) in six different situations: stranger, ... recorded with a tape recorder before being transferred to ...
... The juries of the BBVA Foundation Awards for Biodiversity ... edition of the scheme. The Award for Scientific Research ... been granted ex aequo to leading scientists Harold Mooney ... Conservation projects in Latin America, with prize money of ...
... Isochronous Capability Enhances Company,s Leadership in USB Networking ... ... Silex Technology today,announced the SX-2000WG+ USB device server with isochronous ... like,webcams and speakers to be easily shared among multiple Windows and,Macintosh ...
Cached Biology News:Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology 2Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology 3Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology 4Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology 5Silex Introduces World's First Wireless USB Device Server With Streaming Video and Audio Data Transfer 2
... Immunogen: Synthetic peptide derived from the ... mouse dog and orangutang occludin proteins. ... occludin protein. Reactivity: Human (positive ... with rat mouse dog and orangutang ...
...
... protein western blot (WtPAN) is ... specific protein expression in plant ... is included in each blot ... comparison between different western blots. ...
... Water is suitable for use ... by incubating with 0.1% diethylpyrocarbonate ... remove the DEPC.DNase/RNase-Free Distilled WaterDistilled ... in all molecular biology applications. ...
Biology Products: